|
AU509682B2
(en)
|
1975-10-28 |
1980-05-22 |
Eli Lilly And Company |
2-Aroyl-3-Phenylbenzothiophene Derivatives
|
|
US4133814A
(en)
|
1975-10-28 |
1979-01-09 |
Eli Lilly And Company |
2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
|
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
|
EP0146243A1
(en)
|
1983-10-31 |
1985-06-26 |
Merck Frosst Canada Inc. |
Lipoxygenase inhibitors
|
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
|
EP0752421B1
(en)
|
1995-07-07 |
2005-10-12 |
AstraZeneca AB |
Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
|
|
US6458811B1
(en)
|
1996-03-26 |
2002-10-01 |
Eli Lilly And Company |
Benzothiophenes formulations containing same and methods
|
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
|
TW397821B
(en)
|
1996-04-19 |
2000-07-11 |
American Home Produits Corp |
3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
|
|
CA2306489A1
(en)
|
1997-10-03 |
1999-04-15 |
Mark Gregory Stocksdale |
Benzothiophenes
|
|
US6326392B1
(en)
|
1997-11-06 |
2001-12-04 |
American Home Products Corporation |
Anti-estrogen plus progestin containing oral contraceptives
|
|
ID24568A
(id)
|
1997-11-06 |
2000-07-27 |
American Home Prod |
Kontrasepsi oral yang mengandung anti-estrogen plus progestin
|
|
US6060488A
(en)
*
|
1998-09-22 |
2000-05-09 |
Eli Lilly And Company |
Benzothiophenes for treating estrogen deficiency
|
|
CO5271696A1
(es)
|
2000-01-12 |
2003-04-30 |
Pfizer Prod Inc |
Procedimiento para reducir la morbilidad y el riesgo de mortalidad
|
|
US7091240B2
(en)
|
2000-03-10 |
2006-08-15 |
Oxigene, Inc. |
Tubulin binding ligands and corresponding prodrug constructs
|
|
BR0112360A
(pt)
|
2000-07-06 |
2003-05-06 |
Wyeth Corp |
Método para aumentar a atividade da sintase de óxido nìtrico
|
|
WO2002003988A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating neuropeptide y-related conditions
|
|
AU2001271784A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Therapy for prosthesis-related bone degeneration
|
|
JP2004502731A
(ja)
|
2000-07-06 |
2004-01-29 |
ワイス |
スタチン、エストロゲン剤および所望によるエストロゲンの組み合わせ
|
|
AR030064A1
(es)
|
2000-07-06 |
2003-08-13 |
Wyeth Corp |
Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
|
|
EP1299093A2
(en)
|
2000-07-06 |
2003-04-09 |
Wyeth |
Combinations of bisphosphonates, estrogenic agents and optionally estrogens
|
|
WO2002003990A2
(en)
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted insole compounds for treating excessive intraocular pressure
|
|
CN1452497A
(zh)
|
2000-07-06 |
2003-10-29 |
惠氏公司 |
Ssri和雌激素制剂的联合药物形式
|
|
AU2001271781A1
(en)
|
2000-07-06 |
2002-01-21 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
US20020016318A1
(en)
|
2000-07-06 |
2002-02-07 |
American Home Products Corporation |
Methods of treating breast disorders
|
|
ATE278421T1
(de)
|
2000-08-11 |
2004-10-15 |
Wyeth Corp |
Verfahren zur behandlung eines östrogenrezeptor positives karzinoms
|
|
ATE423122T1
(de)
|
2003-08-15 |
2009-03-15 |
Astrazeneca Ab |
Kondensierte heterocyclen als inhibitoren von glutamatracemase (muri)
|
|
FR2862646B1
(fr)
|
2003-11-20 |
2006-02-24 |
Merck Sante Sas |
Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
|
|
AU2006206446A1
(en)
|
2005-01-21 |
2006-07-27 |
Janssen Pharmaceutica N.V. |
Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors
|
|
WO2006084338A1
(en)
|
2005-02-14 |
2006-08-17 |
Bionomics Limited |
Novel tubulin polymerisation inhibitors
|
|
CA2640678C
(en)
|
2006-02-03 |
2015-03-31 |
Bionomics Limited |
Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
|
|
CA2656067C
(en)
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
|
EP1947085A1
(en)
|
2007-01-19 |
2008-07-23 |
Laboratorios del Dr. Esteve S.A. |
Substituted indole sulfonamide compounds, their preparation and use as medicaments
|
|
US7534788B2
(en)
|
2007-07-25 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Benzofuran and benzothiophene-2-carboxylic acid amide derivatives
|
|
WO2010093578A1
(en)
|
2009-02-10 |
2010-08-19 |
Glaxo Group Limited |
Indolinyl-, benzofuranyl-, and benzothienyl- amides as modulators of chemokine receptors
|
|
US8809382B2
(en)
|
2009-05-04 |
2014-08-19 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
5-oxo-ETE receptor antagonist compounds
|
|
HRP20170786T1
(hr)
|
2010-06-10 |
2017-08-11 |
Seragon Pharmaceuticals, Inc. |
Modulatori estrogenskog receptora i njihove uporabe
|
|
GB2483736B
(en)
|
2010-09-16 |
2012-08-29 |
Aragon Pharmaceuticals Inc |
Estrogen receptor modulators and uses thereof
|
|
JP5886873B2
(ja)
|
2010-12-24 |
2016-03-16 |
メルク・シャープ・エンド・ドーム・ベー・フェー |
Ｎ置換アゼチジン誘導体
|
|
DE102011087987A1
(de)
|
2011-12-08 |
2013-06-13 |
Bayer Intellectual Property Gmbh |
6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
MX357496B
(es)
|
2011-12-14 |
2018-07-11 |
Seragon Pharmaceuticals Inc |
Moduladores del receptor de estrógenos fluorados y sus usos.
|
|
AU2012353660A1
(en)
|
2011-12-16 |
2014-06-12 |
Olema Pharmaceuticals, Inc. |
Novel benzopyran compounds, compositions and uses thereof
|
|
AU2013215251A1
(en)
|
2012-01-31 |
2014-08-14 |
Novartis Ag |
Combination of a RTK inhibitor with an anti - estrogen and use thereof for the treatment of cancer
|
|
AU2013235499A1
(en)
|
2012-03-20 |
2014-09-25 |
Seragon Pharmaceuticals, Inc. |
Estrogen receptor modulators and uses thereof
|
|
US9475791B2
(en)
|
2012-10-24 |
2016-10-25 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating estrogen-related medical disorders
|
|
WO2014066695A1
(en)
|
2012-10-24 |
2014-05-01 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating estrogen-related medical disorders
|
|
WO2014130310A1
(en)
|
2013-02-19 |
2014-08-28 |
Novartis Ag |
Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
|
|
KR20150129723A
(ko)
|
2013-03-14 |
2015-11-20 |
세라곤 파마슈티컬스, 인크. |
다환형 에스트로겐 수용체 조절제 및 이의 용도
|
|
TN2015000516A1
(en)
|
2013-05-28 |
2017-04-06 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2014203132A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Substituted benzopyran compounds, compositions and uses thereof
|
|
WO2014203129A1
(en)
|
2013-06-19 |
2014-12-24 |
Olema Pharmaceuticals, Inc. |
Combinations of benzopyran compounds, compositions and uses thereof
|
|
CA2915534A1
(en)
|
2013-06-19 |
2014-12-24 |
Seragon Pharmaceuticals, Inc. |
Azetidine estrogen receptor modulators and uses thereof
|
|
UA117249C2
(uk)
|
2013-06-19 |
2018-07-10 |
Серагон Фармасьютікалз, Інк. |
Модулятор рецептора естрогену та його застосування
|
|
GB201311888D0
(en)
*
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
WO2015028409A1
(de)
|
2013-08-27 |
2015-03-05 |
Bayer Pharma Aktiengesellschaft |
6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
|
|
WO2015092634A1
(en)
|
2013-12-16 |
2015-06-25 |
Novartis Ag |
1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
|
|
RU2016137150A
(ru)
|
2014-03-13 |
2018-04-18 |
Ф. Хоффманн-Ля Рош Аг |
Способы и композиции для модулирования мутантов эстрогеновых рецепторов
|
|
CN106572990A
(zh)
|
2014-03-13 |
2017-04-19 |
豪夫迈·罗氏有限公司 |
含有雌激素受体调节剂的治疗性组合产品
|
|
DK3834824T3
(da)
|
2014-03-28 |
2025-12-01 |
Univ Duke |
Behandling af en østrogenreceptor-positiv brystkræft under anvendelse af en selektiv østrogenreceptormodulator
|
|
JP2017538727A
(ja)
|
2014-12-18 |
2017-12-28 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
癌の治療に有用な２，３−ジフェニルクロメンの誘導体
|
|
EA032311B1
(ru)
|
2014-12-18 |
2019-05-31 |
Ф. Хоффманн-Ля Рош Аг |
Тетрагидро-пиридо[3,4-b]индоловые модуляторы эстрогеновых рецепторов и их применение
|
|
EP3233828B1
(en)
|
2014-12-18 |
2020-03-04 |
F. Hoffmann-La Roche AG |
Estrogen receptor modulators and uses thereof
|
|
WO2016189011A1
(en)
|
2015-05-26 |
2016-12-01 |
F. Hoffmann-La Roche Ag |
Heterocyclic estrogen receptor modulators and uses thereof
|
|
HUE055321T2
(hu)
|
2015-10-01 |
2021-11-29 |
Olema Pharmaceuticals Inc |
Tetrahidro-1H-pirido[3,4-b]indol anti-ösztrogén hatóanyagok
|
|
WO2017056115A1
(en)
|
2015-10-03 |
2017-04-06 |
Sun Pharma Advanced Research Company Limited |
Novel n-aryl containing fused heterocyclic compounds
|
|
JP2018533561A
(ja)
|
2015-10-07 |
2018-11-15 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
（ｅ）−３−（４−（（ｅ）−２−（２−クロロ−４−フルオロフェニル）−１−（１ｈ−インダゾール−５−イル）ブタ−１−エン−１−イル）フェニル）アクリル酸を調製するためのプロセス
|
|
US10865199B2
(en)
|
2015-10-27 |
2020-12-15 |
Sun Pharma Advanced Research Company Limited |
Heterocyclic antiestrogens
|
|
CA3008020C
(en)
|
2015-12-09 |
2024-02-20 |
The Board Of Trustees Of The University Of Illinois |
Benzothiophene-based selective estrogen receptor downregulators
|
|
EP3524600B1
(en)
|
2016-02-15 |
2021-11-17 |
Sanofi |
Processes and intermediates for the preparation of novel substituted 6,7-dihydro-5h-benzo[7]annulene compounds
|